Published in Cardiovascular Week, January 10th, 2011
"These were reviewed to determine whether they were ADR (in which the study cohort, exposure, or outcome was defined using electronic data created for or during the processing of patients through their health care). We used...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.